摘要
Hepatitis C (HCV) infection has an estimated global prevalence of 2.5%,causing chronic liver disease in 170 million people worldwide.Recent data has identified HCV infection as a risk factor for subclinical and clinical cardiovascular disease (CVD),but these data have been mixed and whether HCV is an independent risk factor for development of CVD remains controversial.In this review,we present the literature regarding the association of HCV with subclinical and clinical CVD and the possible underlying mechanisms leading to increased CVD among those infected with HCV.HCV infection leads to increased CVD via direct and indirect mechanisms with chronic inflammation,endothelial dysfunction and direct invasion of the arterial wall cited as possible mechanisms.Our review showed that HCV infection,particularly chronic HCV infection,appears to lead to increased subclinical CVD most consistently and potentially also to increased clinical CVD outcomes,leading to increased morbidity and mortality.Furthermore,the majority of studies evaluating the impact of HCV therapy on CVD morbidity and mortality showed an improvement in subclinical and clinical CVD endpoints in patients who were successfully treated and achieved sustained viral suppression.These results are of particular interest following the development of new direct antiviral agents which have made HCV eradication simple and feasible for many more patients globally,and in doing so may possibly reduce CVD morbidity and mortality in those with chronic HCV infection.
作者简介
Corresponding author:Shashwatee Bagchi,Division of Infectious Diseases,Uni­versity of Maryland School of Medicine,725 West Lombard Street,N3S9,Balti­more,MD 21201,USA.Tel:+1-410-706-4606,Fax:+1-410-706-3243,E-mail:sbagchi@som.umaryland.edu
